Schlegel Amnon, Stainier Didier Y R
Department of Biochemistry and Biophysics, Division of Endocrinology at the University of California San Francisco, San Francisco, California, United States of America.
PLoS Genet. 2007 Nov;3(11):e199. doi: 10.1371/journal.pgen.0030199.
A pandemic of metabolic diseases (atherosclerosis, diabetes mellitus, and obesity), unleashed by multiple social and economic factors beyond the control of most individuals, threatens to diminish human life span for the first time in the modern era. Given the redundancy and inherent complexity of processes regulating the uptake, transport, catabolism, and synthesis of nutrients, magic bullets to target these diseases will be hard to find. Recent studies using the worm Caenorhabditis elegans, the fly Drosophila melanogaster, and the zebrafish Danio rerio indicate that these "lower" metazoans possess unique attributes that should help in identifying, investigating, and even validating new pharmaceutical targets for these diseases. We summarize findings in these organisms that shed light on highly conserved pathways of energy homeostasis.
由多数人无法控制的多种社会和经济因素引发的代谢性疾病(动脉粥样硬化、糖尿病和肥胖症)大流行,有可能在现代首次缩短人类寿命。鉴于调节营养物质摄取、运输、分解代谢和合成的过程具有冗余性和内在复杂性,很难找到针对这些疾病的神奇药物。最近使用秀丽隐杆线虫、黑腹果蝇和斑马鱼进行的研究表明,这些“低等”后生动物具有独特的特性,有助于识别、研究甚至验证针对这些疾病的新药物靶点。我们总结了这些生物体中的研究结果,这些结果揭示了能量稳态的高度保守途径。